Xavier Cheng, Ph.D.
Analyst
Bio
Xavier Cheng, Ph.D. joined OrbiMed in 2021 and is an Analyst on the Public Equity team. Prior to joining OrbiMed, Xavier worked at L.E.K. Consulting as a Life Sciences Consultant, advising biopharma and investment clients on deals and growth strategy. Previously, he worked at Foster Rosenblatt as an Associate Director on the Biopharma Team. Xavier holds a Ph.D. in Chemistry and a B.S. in Biological Chemistry from the University of Toronto.
